was successfully added to your cart.


Is Collateral OTC Clearing’s Double-edged Sword?

By 3 Feb, 2014 February 15th, 2018 Blog, Sellside Trends
New capital markets regulations in the EU and US impose limits on the ability of investment banks to post high-yield fixed income securities to central counterparty clearinghouses (CCPs) as collateral against both proprietary and buyside client OTC derivatives trades.
Limits on the use by banks of only high-grade collateral to novate derivatives trades at CCPs raises the question: Is there enough long-term supply of high-grade collateral available in the market to match capital markets demand for the fixed income securities?
GreySpark Partners consultant Malavika Shekar explores issues related to the pro-cyclical nature of collateral in the clearing world.

This content is restricted to site members. If you are an existing user, please log in. New users may register below.



Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy.

Scroll Up